Eckert & Ziegler SE (BIT:1EUZ)

Italy flag Italy · Delayed Price · Currency is EUR
15.59
+0.15 (0.97%)
At close: Dec 5, 2025
1.45%
Market Cap 968.02M
Revenue (ttm) 304.47M
Net Income (ttm) 39.75M
Shares Out n/a
EPS (ttm) 0.63
PE Ratio 24.35
Forward PE 19.60
Dividend 0.17 (1.05%)
Ex-Dividend Date Jun 19, 2025
Volume n/a
Average Volume n/a
Open n/a
Previous Close 15.44
Day's Range n/a
52-Week Range 14.30 - 22.83
Beta n/a
RSI 40.72
Earnings Date Nov 13, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co... [Read more]

Industry Industrial Inorganic Chemicals
Founded 1992
Employees 1,085
Stock Exchange Borsa Italiana
Ticker Symbol 1EUZ
Full Company Profile

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.

Financial Statements

News

There is no news available yet.